Cargando…

Protease-Activated Receptor 2 Promotes Pro-Atherogenic Effects through Transactivation of the VEGF Receptor 2 in Human Vascular Smooth Muscle Cells

Background: Obesity is associated with impaired vascular function. In the cardiovascular system, protease-activated receptor 2 (PAR2) exerts multiple functions such as the control of the vascular tone. In pathological conditions, PAR2 is related to vascular inflammation. However, little is known abo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indrakusuma, Ira, Romacho, Tania, Eckel, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209375/ https://www.ncbi.nlm.nih.gov/pubmed/28101054 http://dx.doi.org/10.3389/fphar.2016.00497

Ejemplares similares

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016)

Lipopolysaccharide acting via toll-like receptor 4 transactivates the TGF-β receptor in vascular smooth muscle cells
por: Afroz, Rizwana, et al.
Publicado: (2022)

Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells
por: Yang, Haiyan, et al.
Publicado: (2022)

RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells
por: Kamato, Danielle, et al.
Publicado: (2017)

Positive allosteric GABA(A) receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes in vitro
por: Rohbeck, Elisabeth, et al.
Publicado: (2023)

Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction
por: Prado, Alejandro F., et al.
Publicado: (2018)

Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells
por: Kamato, Danielle, et al.
Publicado: (2022)

Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
por: ENJOJI, Shuhei, et al.
Publicado: (2014)

TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells
por: Walcher, Lia, et al.
Publicado: (2018)

Phytanic acid activates NADPH oxidase through transactivation of epidermal growth factor receptor in vascular smooth muscle cells
por: Dhaunsi, Gursev S., et al.
Publicado: (2016)

Activin receptor-like kinase 7 promotes apoptosis of vascular smooth muscle cells via activating Smad2/3 signaling in diabetic atherosclerosis
por: Cao, Shengchuan, et al.
Publicado: (2022)

Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries
por: Villari, Ambra, et al.
Publicado: (2017)

Drynaria fortunei Promoted Angiogenesis Associated With Modified MMP-2/TIMP-2 Balance and Activation of VEGF Ligand/Receptors Expression
por: Huang, Sheng-Teng, et al.
Publicado: (2018)

Upregulation of Protease-Activated Receptor 2 Promotes Proliferation and Migration of Human Vascular Smooth Muscle Cells (VSMCs)
por: Wei, Mei, et al.
Publicado: (2019)

Contribution of oxidative stress and growth factor receptor transactivation in natriuretic peptide receptor C-mediated attenuation of hyperproliferation of vascular smooth muscle cells from SHR
por: Rahali, Sofiane, et al.
Publicado: (2018)

Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1
por: Rasmussen, Jeppe Grøndahl, et al.
Publicado: (2012)

Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
por: Zuo, Pengfei, et al.
Publicado: (2017)

Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle
por: Al-aryahi, Sefaa, et al.
Publicado: (2014)

Protease Activated Receptor-2 Expression and Function in Asthmatic Bronchial Smooth Muscle
por: Allard, Benoit, et al.
Publicado: (2014)

Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter
por: Zhang, Jing, et al.
Publicado: (2014)

VEGF/Flk1 Signaling Cascade Transactivates Etv2 Gene Expression
por: Rasmussen, Tara L., et al.
Publicado: (2012)

Sustained Contraction in Vascular Smooth Muscle by Activation of L-type Ca(2+) Channels Does Not Involve Ca(2+) Sensitization or Caldesmon
por: Ets, Hillevi K., et al.
Publicado: (2016)

Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
por: Liu, Qing-Rong, et al.
Publicado: (2022)

Protease-Activated Receptor-1 Antagonist Protects Against Lung Ischemia/Reperfusion Injury
por: Chu, Shi-Jye, et al.
Publicado: (2021)

Protease-activated receptor 2 promotes clearance of Pseudomonas aeruginosa infection by inducing cAMP-Rac1 signaling in alveolar macrophages
por: Rayees, Sheikh, et al.
Publicado: (2022)

CysLT(1 )receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation
por: Ravasi, Saula, et al.
Publicado: (2006)

Corrigendum: Sustained Contraction in Vascular Smooth Muscle by Activation of L-type Ca(2+) Channels Does Not Involve Ca(2+) Sensitization or Caldesmon
por: Ets, Hillevi K., et al.
Publicado: (2017)

Inhibitory effect of (pro)renin receptor decoy inhibitor PRO20 on endoplasmic reticulum stress during cardiac remodeling
por: Zhang, Jing, et al.
Publicado: (2022)

Arsenic Exposure Increases Monocyte Adhesion to the Vascular Endothelium, a Pro-Atherogenic Mechanism
por: Lemaire, Maryse, et al.
Publicado: (2015)

Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
por: Velayutham, Naveen Kumar, et al.
Publicado: (2023)

Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia
por: Artiach, Gonzalo, et al.
Publicado: (2018)

Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
por: Jiang, Yuhong, et al.
Publicado: (2021)

Editorial: Vascular smooth muscle cell fate and vascular remodeling: Mechanisms, therapeutic targets, and drugs, volume I
por: Wang, Qilong, et al.
Publicado: (2022)

Computer-aided drug design for virtual-screening and active-predicting of main protease (M(pro)) inhibitors against SARS-CoV-2
por: Dai, Renhui, et al.
Publicado: (2023)

Bilirubin Inhibits Neointima Formation and Vascular Smooth Muscle Cell Proliferation and Migration
por: Peyton, Kelly J., et al.
Publicado: (2012)

Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy
por: Mondaca-Ruff, David, et al.
Publicado: (2019)

Histone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases
por: Wang, Fang, et al.
Publicado: (2020)

Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function
por: Deng, Mingying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kjknhqpq0aeeqlgpoe6m4bn5bo